Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Umbricht

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Neuroscience|December 22, 2022
Not Mismatch Negativity, but Modulation of Sensory N1 is Measured - Comment to Chen-Engerer et alDaniel Umbricht
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 8, 2021
Matrix metalloproteinase 9 levels and parvalbumin positive interneuron dysfunctionDaniel Umbricht
Biological Psychiatry|September 1, 2018
Nailing the Right Dose! The Key for Developing Glycine Transporter Inhibitors for SchizophreniaDaniel Umbricht
Schizophrenia Research|June 2, 2005
Mismatch negativity in schizophrenia: a meta-analysisDaniel Umbricht, Sanya Krljes
Swiss Medical Weekly|March 20, 2003
Atypical antipsychotics in the treatment of schizophreniaRené Bridler, Daniel Umbricht
Schizophrenia Research|October 27, 2009
High remission rates from an initial ultra-high risk state for psychosisAndor E Simon, Daniel Umbricht
Archives of General Psychiatry|August 5, 2009
Is elevated striatal dopamine function a prodromal sign of schizophrenia?Andor E Simon, Daniel Umbricht
Schizophrenia Research|July 30, 2023
Negative symptoms in schizophrenia: Newly emerging measurements, pathways, and treatmentsStephen R Marder, Daniel Umbricht
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 23, 2007
Early auditory sensory processing deficits in mouse mutants with reduced NMDA receptor functionStephan Bickel, Hans-Peter Lipp, Daniel Umbricht
Epidemiologia E Psichiatria Sociale|January 26, 2011
Primary care and the early phases of schizophrenia in the Czech RepublicDavid Holub, Barbora Wenigová, Daniel Umbricht, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Neuroscience|December 22, 2022
Not Mismatch Negativity, but Modulation of Sensory N1 is Measured - Comment to Chen-Engerer et alDaniel Umbricht
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 8, 2021
Matrix metalloproteinase 9 levels and parvalbumin positive interneuron dysfunctionDaniel Umbricht
Biological Psychiatry|September 1, 2018
Nailing the Right Dose! The Key for Developing Glycine Transporter Inhibitors for SchizophreniaDaniel Umbricht
Schizophrenia Research|June 2, 2005
Mismatch negativity in schizophrenia: a meta-analysisDaniel Umbricht, Sanya Krljes
Swiss Medical Weekly|March 20, 2003
Atypical antipsychotics in the treatment of schizophreniaRené Bridler, Daniel Umbricht
Schizophrenia Research|October 27, 2009
High remission rates from an initial ultra-high risk state for psychosisAndor E Simon, Daniel Umbricht
Archives of General Psychiatry|August 5, 2009
Is elevated striatal dopamine function a prodromal sign of schizophrenia?Andor E Simon, Daniel Umbricht
Schizophrenia Research|July 30, 2023
Negative symptoms in schizophrenia: Newly emerging measurements, pathways, and treatmentsStephen R Marder, Daniel Umbricht
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 23, 2007
Early auditory sensory processing deficits in mouse mutants with reduced NMDA receptor functionStephan Bickel, Hans-Peter Lipp, Daniel Umbricht
Epidemiologia E Psichiatria Sociale|January 26, 2011
Primary care and the early phases of schizophrenia in the Czech RepublicDavid Holub, Barbora Wenigová, Daniel Umbricht, et al.
Pageof 8